The Latest Analyst Ratings for Amgen
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 8 analysts have published their opinion on Amgen (NASDAQ:AMGN) stock. The company has an average price target of $252.0 with a high of $310.00 and a low of $200.00. The average price target has increased by 3.99% over the past month.
August 14, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amgen's stock has received mixed reviews from analysts over the past 3 months, with an average price target of $252.0. The average price target has increased by 3.99% over the past month.
The mixed reviews from analysts indicate uncertainty about the stock's future performance. However, the increase in the average price target over the past month suggests a positive outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100